655 related articles for article (PubMed ID: 26883165)
1. Mitochondrial dysfunction and cell death in neurodegenerative diseases through nitroxidative stress.
Akbar M; Essa MM; Daradkeh G; Abdelmegeed MA; Choi Y; Mahmood L; Song BJ
Brain Res; 2016 Apr; 1637():34-55. PubMed ID: 26883165
[TBL] [Abstract][Full Text] [Related]
2. Oxidative Stress: A Key Modulator in Neurodegenerative Diseases.
Singh A; Kukreti R; Saso L; Kukreti S
Molecules; 2019 Apr; 24(8):. PubMed ID: 31013638
[TBL] [Abstract][Full Text] [Related]
3. Oxidative stress, mitochondrial dysfunction and cellular stress response in Friedreich's ataxia.
Calabrese V; Lodi R; Tonon C; D'Agata V; Sapienza M; Scapagnini G; Mangiameli A; Pennisi G; Stella AM; Butterfield DA
J Neurol Sci; 2005 Jun; 233(1-2):145-62. PubMed ID: 15896810
[TBL] [Abstract][Full Text] [Related]
4. Mitochondrial dysfunction and tissue injury by alcohol, high fat, nonalcoholic substances and pathological conditions through post-translational protein modifications.
Song BJ; Akbar M; Abdelmegeed MA; Byun K; Lee B; Yoon SK; Hardwick JP
Redox Biol; 2014; 3():109-23. PubMed ID: 25465468
[TBL] [Abstract][Full Text] [Related]
5. Mitochondria, metabolic disturbances, oxidative stress and the kynurenine system, with focus on neurodegenerative disorders.
Sas K; Robotka H; Toldi J; Vécsei L
J Neurol Sci; 2007 Jun; 257(1-2):221-39. PubMed ID: 17462670
[TBL] [Abstract][Full Text] [Related]
6. Neurological disorders and mitochondria.
Cabral-Costa JV; Kowaltowski AJ
Mol Aspects Med; 2020 Feb; 71():100826. PubMed ID: 31630771
[TBL] [Abstract][Full Text] [Related]
7. Mitochondrial dysfunction and oxidative stress in Alzheimer's disease, and Parkinson's disease, Huntington's disease and Amyotrophic Lateral Sclerosis -An updated review.
Alqahtani T; Deore SL; Kide AA; Shende BA; Sharma R; Dadarao Chakole R; Nemade LS; Kishor Kale N; Borah S; Shrikant Deokar S; Behera A; Dhawal Bhandari D; Gaikwad N; Kalam Azad A; Ghosh A
Mitochondrion; 2023 Jul; 71():83-92. PubMed ID: 37269968
[TBL] [Abstract][Full Text] [Related]
8. Mitochondrial medicine for aging and neurodegenerative diseases.
Reddy PH
Neuromolecular Med; 2008; 10(4):291-315. PubMed ID: 18566920
[TBL] [Abstract][Full Text] [Related]
9. Potential for therapeutic use of hydrogen sulfide in oxidative stress-induced neurodegenerative diseases.
Tabassum R; Jeong NY
Int J Med Sci; 2019; 16(10):1386-1396. PubMed ID: 31692944
[TBL] [Abstract][Full Text] [Related]
10. Mitochondria, oxidative stress and neurodegeneration.
Federico A; Cardaioli E; Da Pozzo P; Formichi P; Gallus GN; Radi E
J Neurol Sci; 2012 Nov; 322(1-2):254-62. PubMed ID: 22669122
[TBL] [Abstract][Full Text] [Related]
11. Mitochondrial dysfunction in neurodegenerative diseases and drug targets via apoptotic signaling.
Wu Y; Chen M; Jiang J
Mitochondrion; 2019 Nov; 49():35-45. PubMed ID: 31288090
[TBL] [Abstract][Full Text] [Related]
12. Reactive oxygen species: stuck in the middle of neurodegeneration.
Patten DA; Germain M; Kelly MA; Slack RS
J Alzheimers Dis; 2010; 20 Suppl 2():S357-67. PubMed ID: 20421690
[TBL] [Abstract][Full Text] [Related]
13. Oxidative Stress and Mitochondrial Dysfunction in Human Diseases: Pathophysiology, Predictive Biomarkers, Therapeutic.
Li CJ
Biomolecules; 2020 Nov; 10(11):. PubMed ID: 33207541
[TBL] [Abstract][Full Text] [Related]
14. Mitochondria, oxidative stress, and temporal lobe epilepsy.
Waldbaum S; Patel M
Epilepsy Res; 2010 Jan; 88(1):23-45. PubMed ID: 19850449
[TBL] [Abstract][Full Text] [Related]
15. Emerging Promise of Therapeutic Approaches Targeting Mitochondria in Neurodegenerative Disorders.
Rahman MM; Tumpa MAA; Rahaman MS; Islam F; Sutradhar PR; Ahmed M; Alghamdi BS; Hafeez A; Alexiou A; Perveen A; Ashraf GM
Curr Neuropharmacol; 2023; 21(5):1081-1099. PubMed ID: 36927428
[TBL] [Abstract][Full Text] [Related]
16. Targetable Pathways for Alleviating Mitochondrial Dysfunction in Neurodegeneration of Metabolic and Non-Metabolic Diseases.
Millichap LE; Damiani E; Tiano L; Hargreaves IP
Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34768878
[TBL] [Abstract][Full Text] [Related]
17. Mitochondrial Biology and Neurological Diseases.
Arun S; Liu L; Donmez G
Curr Neuropharmacol; 2016; 14(2):143-54. PubMed ID: 26903445
[TBL] [Abstract][Full Text] [Related]
18. MicroRNAs Dysregulation and Mitochondrial Dysfunction in Neurodegenerative Diseases.
Catanesi M; d'Angelo M; Tupone MG; Benedetti E; Giordano A; Castelli V; Cimini A
Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32825273
[TBL] [Abstract][Full Text] [Related]
19. Impairment of glucose and glutamate transport and induction of mitochondrial oxidative stress and dysfunction in synaptosomes by amyloid beta-peptide: role of the lipid peroxidation product 4-hydroxynonenal.
Keller JN; Pang Z; Geddes JW; Begley JG; Germeyer A; Waeg G; Mattson MP
J Neurochem; 1997 Jul; 69(1):273-84. PubMed ID: 9202320
[TBL] [Abstract][Full Text] [Related]
20. FOXO and related transcription factors binding elements in the regulation of neurodegenerative disorders.
Oli V; Gupta R; Kumar P
J Chem Neuroanat; 2021 Oct; 116():102012. PubMed ID: 34400291
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
